Israel Englander Aldeyra Therapeutics, Inc. Transaction History
Millennium Management LLC
- $224 Billion
- Q1 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 388,705 shares of ALDX stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
388,705
Previous 440,388
11.74%
Holding current value
$1.5 Million
Previous $1.55 Million
17.73%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding ALDX
# of Institutions
106Shares Held
35.4MCall Options Held
104KPut Options Held
88.1K-
Perceptive Advisors LLC New York, NY8.59MShares$33.2 Million0.59% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$21.1 Million11.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$14.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.31MShares$12.8 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.32MShares$5.09 Million0.09% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $225M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...